<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04146558</url>
  </required_header>
  <id_info>
    <org_study_id>GI012019</org_study_id>
    <nct_id>NCT04146558</nct_id>
  </id_info>
  <brief_title>Ayurvedic Treatment Package in Plaque Psoriasis</brief_title>
  <official_title>A Randomized Open Label Clinical Trial on the Efficacy of an Ayurvedic Treatment Package on Symptom Severity and Quality of Life in Plaque Psoriasis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universität Duisburg-Essen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Poomulli Neelakandan Namboodiripad Memorial Ayurveda Medical College</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universität Duisburg-Essen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Psoriasis is a chronic, immune-mediated inflammatory skin disease that is associated with
      substantial impairment of physical and psychological quality of life. The conventional
      treatment protocols manages the condition but with remissions and relapses which create
      anxiety in patients. Many of the patients withdraw from active social life as the disease
      attains chronicity. Several studies are pointing towards a conjoint management strategy
      incorporating the traditional and alternate medical systems. In this regard, Ayurveda is
      commonly used by psoriatic patients in India. Considering this fact it is high time to
      conduct a study to scientifically evaluate the efficacy of Ayurvedic treatment protocol in
      managing psoriasis as well as its potential to improve the quality of life.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 4, 2019</start_date>
  <completion_date type="Anticipated">November 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 15, 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Psoriasis-specific quality of life</measure>
    <time_frame>6 months</time_frame>
    <description>Psoriasis specific DLQI scores</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Psoriasis Severity</measure>
    <time_frame>3 months</time_frame>
    <description>Psoriasis Area Severity Index (PASI) score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psoriasis Severity</measure>
    <time_frame>6 months</time_frame>
    <description>Psoriasis Area Severity Index (PASI) score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psoriasis Severity</measure>
    <time_frame>12 months</time_frame>
    <description>Psoriasis Area Severity Index (PASI) score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psoriasis-specific quality of life</measure>
    <time_frame>3 months</time_frame>
    <description>Psoriasis specific DLQI scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psoriasis-specific quality of life</measure>
    <time_frame>12 months</time_frame>
    <description>Psoriasis specific DLQI scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Psoriasis</condition>
  <arm_group>
    <arm_group_label>Internal ayurvedic treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All possible internal preparations will be administered for a period of 12 months.
All administered preparations with its dosage and duration will be documented All preparations will be subjected to lab test for clearing heavy metal and pesticide content before the administration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>External ayurvedic treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Application of warm external oil (Ayyapala kera tailam) on affected parts twice daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Individualized internal ayurvedic treatment</intervention_name>
    <description>All possible internal preparations will be administered for a period of 12 months.
All administered preparations with its dosage and duration will be documented All preparations will be subjected to lab test for clearing heavy metal and pesticide content before the administration</description>
    <arm_group_label>Internal ayurvedic treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>External ayurvedic treatment</intervention_name>
    <description>Application of warm external oil (Ayyapala kera tailam) on affected parts twice daily</description>
    <arm_group_label>External ayurvedic treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with psoriasis having age 18 years or more

          -  Patients with moderate-to-severe plaque psoriasis with a PASI score of 12 or higher

          -  Psoriasis diagnosed 6 months or more before study entry

          -  Those who are poorly controlled based on physicians assessment with topical
             treatments, phototherapy, systemic therapy, or a combination of these therapies.

          -  Participants who have given informed consent.

        Exclusion Criteria:

          -  Participants with other systemic illnesses

          -  Lactating and pregnant mothers.

          -  Alcohol dependence/Narcotic dependence /Steroid dependence

          -  In the judgment of the investigator, unable or unwilling to follow the protocol and
             instructions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Syal Kumar, MD, PhD</last_name>
    <phone>0049 201 - 174 25021</phone>
    <email>s.kumar@kem-med.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>PNNM Ayurveda College</name>
      <address>
        <city>Shoranur</city>
        <state>Kerala</state>
        <zip>679 531</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eswara Sarma, Prof. Dr.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>October 29, 2019</study_first_submitted>
  <study_first_submitted_qc>October 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 31, 2019</study_first_posted>
  <last_update_submitted>December 18, 2019</last_update_submitted>
  <last_update_submitted_qc>December 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universität Duisburg-Essen</investigator_affiliation>
    <investigator_full_name>Gustav Dobos</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psoriasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

